-
3
-
-
84876951761
-
Capecitabine and cisplatin with or without cetuximab for patients with previously untreated advanced gastric cancer (expand): a randomised, open-label phase 3 trial
-
COI: 1:CAS:528:DC%2BC3sXmt1OntLw%3D, PID: 23594786
-
Lordick F, Kang YK, Chung HC, Salman P, Oh SC, Bodoky G, et al. Capecitabine and cisplatin with or without cetuximab for patients with previously untreated advanced gastric cancer (expand): a randomised, open-label phase 3 trial. Lancet Oncol. 2013;14:490–9.
-
(2013)
Lancet Oncol
, vol.14
, pp. 490-499
-
-
Lordick, F.1
Kang, Y.K.2
Chung, H.C.3
Salman, P.4
Oh, S.C.5
Bodoky, G.6
-
4
-
-
84876992498
-
Epirubicin, oxaliplatin, and capecitabine with or without panitumumab for patients with previously untreated advanced oesophagogastric cancer (REAL3): a randomised, open-label phase 3 trial
-
COI: 1:CAS:528:DC%2BC3sXmt1Oksb0%3D, PID: 23594787
-
Waddell T, Chau I, Cunningham D, Gonzalez D, Okines AF, Okines C, et al. Epirubicin, oxaliplatin, and capecitabine with or without panitumumab for patients with previously untreated advanced oesophagogastric cancer (REAL3): a randomised, open-label phase 3 trial. Lancet Oncol. 2013;14:481–9.
-
(2013)
Lancet Oncol
, vol.14
, pp. 481-489
-
-
Waddell, T.1
Chau, I.2
Cunningham, D.3
Gonzalez, D.4
Okines, A.F.5
Okines, C.6
-
5
-
-
0037180757
-
Inflammation and cancer
-
COI: 1:CAS:528:DC%2BD38XpsFygtb4%3D, PID: 12490959
-
Coussens LM, Werb Z. Inflammation and cancer. Nature. 2002;420:860–7.
-
(2002)
Nature
, vol.420
, pp. 860-867
-
-
Coussens, L.M.1
Werb, Z.2
-
6
-
-
47949096781
-
Cancer-related inflammation
-
COI: 1:CAS:528:DC%2BD1cXovV2mtbg%3D, PID: 18650914
-
Mantovani A, Allavena P, Sica A, Balkwill F. Cancer-related inflammation. Nature. 2008;454:436–44.
-
(2008)
Nature
, vol.454
, pp. 436-444
-
-
Mantovani, A.1
Allavena, P.2
Sica, A.3
Balkwill, F.4
-
7
-
-
77950346282
-
Immunity, inflammation, and cancer
-
COI: 1:CAS:528:DC%2BC3cXlsVSgu7g%3D, PID: 20303878
-
Grivennikov SI, Greten FR, Karin M. Immunity, inflammation, and cancer. Cell. 2010;140:883–99.
-
(2010)
Cell
, vol.140
, pp. 883-899
-
-
Grivennikov, S.I.1
Greten, F.R.2
Karin, M.3
-
8
-
-
84863724868
-
Prognostic importance of the inflammation-based Glasgow prognostic score in patients with gastric cancer
-
COI: 1:CAS:528:DC%2BC38XhtVels7fM, PID: 22713657
-
Jiang X, Hiki N, Nunobe S, Kumagai K, Kubota T, Aikou S, et al. Prognostic importance of the inflammation-based Glasgow prognostic score in patients with gastric cancer. Br J Cancer. 2012;107:275–9.
-
(2012)
Br J Cancer
, vol.107
, pp. 275-279
-
-
Jiang, X.1
Hiki, N.2
Nunobe, S.3
Kumagai, K.4
Kubota, T.5
Aikou, S.6
-
9
-
-
84919399351
-
-
Pre-treatment neutrophil to lymphocyte ratio as a prognostic marker to predict chemotherapeutic response and survival outcomes in metastatic advanced gastric cancer, Gastric Cancer:
-
Cho IR, Park JC, Park CH, Jo JH, Lee HJ, Kim S, Shim CN, Lee H, Shin SK, Lee SK, Lee YC: Pre-treatment neutrophil to lymphocyte ratio as a prognostic marker to predict chemotherapeutic response and survival outcomes in metastatic advanced gastric cancer. Gastric Cancer. 2014. doi: 10.1007/s10120-013-0330-2.
-
(2014)
Lee YC
-
-
Cho, I.R.1
Park, J.C.2
Park, C.H.3
Jo, J.H.4
Lee, H.J.5
Kim, S.6
Shim, C.N.7
Lee, H.8
Shin, S.K.9
Lee, S.K.10
-
10
-
-
84880334569
-
Prognostic significance of neutrophil lymphocyte ratio and platelet lymphocyte ratio in advanced gastric cancer patients treated with FOLFOX chemotherapy
-
COI: 1:CAS:528:DC%2BC3sXht1Ontb3L, PID: 23876227
-
Lee S, Oh SY, Kim SH, Lee JH, Kim MC, Kim KH, et al. Prognostic significance of neutrophil lymphocyte ratio and platelet lymphocyte ratio in advanced gastric cancer patients treated with FOLFOX chemotherapy. BMC Cancer. 2013;13:350.
-
(2013)
BMC Cancer
, vol.13
, pp. 350
-
-
Lee, S.1
Oh, S.Y.2
Kim, S.H.3
Lee, J.H.4
Kim, M.C.5
Kim, K.H.6
-
11
-
-
77957932514
-
High preoperative neutrophil-lymphocyte ratio predicts poor survival in patients with gastric cancer
-
PID: 20820986
-
Shimada H, Takiguchi N, Kainuma O, Soda H, Ikeda A, Cho A, et al. High preoperative neutrophil-lymphocyte ratio predicts poor survival in patients with gastric cancer. Gastric Cancer. 2010;13:170–6.
-
(2010)
Gastric Cancer
, vol.13
, pp. 170-176
-
-
Shimada, H.1
Takiguchi, N.2
Kainuma, O.3
Soda, H.4
Ikeda, A.5
Cho, A.6
-
12
-
-
84864209598
-
Blood lymphocyte-to-monocyte ratio identifies high-risk patients in diffuse large B-cell lymphoma treated with R-CHOP
-
COI: 1:CAS:528:DC%2BC38XhtFSktbnF, PID: 22911837
-
Li ZM, Huang JJ, Xia Y, Sun J, Huang Y, Wang Y, et al. Blood lymphocyte-to-monocyte ratio identifies high-risk patients in diffuse large B-cell lymphoma treated with R-CHOP. PLoS One. 2012;7:e41658.
-
(2012)
PLoS One
, vol.7
, pp. e41658
-
-
Li, Z.M.1
Huang, J.J.2
Xia, Y.3
Sun, J.4
Huang, Y.5
Wang, Y.6
-
13
-
-
84856446578
-
Peripheral blood lymphocyte/monocyte ratio at diagnosis and survival in classical Hodgkin’s lymphoma
-
PID: 21993683
-
Porrata LF, Ristow K, Colgan JP, Habermann TM, Witzig TE, Inwards DJ, et al. Peripheral blood lymphocyte/monocyte ratio at diagnosis and survival in classical Hodgkin’s lymphoma. Haematologica. 2012;97:262–9.
-
(2012)
Haematologica
, vol.97
, pp. 262-269
-
-
Porrata, L.F.1
Ristow, K.2
Colgan, J.P.3
Habermann, T.M.4
Witzig, T.E.5
Inwards, D.J.6
-
14
-
-
84892910540
-
The preoperative lymphocyte to monocyte ratio predicts clinical outcome in patients with stage III colon cancer
-
COI: 1:STN:280:DC%2BC2c3nvFaisQ%3D%3D, PID: 24357796
-
Stotz M, Pichler M, Absenger G, Szkandera J, Arminger F, Schaberl-Moser R, et al. The preoperative lymphocyte to monocyte ratio predicts clinical outcome in patients with stage III colon cancer. Br J Cancer. 2014;110:435–40.
-
(2014)
Br J Cancer
, vol.110
, pp. 435-440
-
-
Stotz, M.1
Pichler, M.2
Absenger, G.3
Szkandera, J.4
Arminger, F.5
Schaberl-Moser, R.6
-
15
-
-
84893558098
-
A large cohort study reveals the association of elevated peripheral blood lymphocyte-to-monocyte ratio with favorable prognosis in nasopharyngeal carcinoma
-
PID: 24386144
-
Li J, Jiang R, Liu WS, Liu Q, Xu M, Feng QS, et al. A large cohort study reveals the association of elevated peripheral blood lymphocyte-to-monocyte ratio with favorable prognosis in nasopharyngeal carcinoma. PLoS One. 2013;8:e83069.
-
(2013)
PLoS One
, vol.8
, pp. e83069
-
-
Li, J.1
Jiang, R.2
Liu, W.S.3
Liu, Q.4
Xu, M.5
Feng, Q.S.6
-
16
-
-
0035901090
-
Inflammation and cancer: back to Virchow?
-
COI: 1:CAS:528:DC%2BD3MXhsVKltb0%3D, PID: 11229684
-
Balkwill F, Mantovani A. Inflammation and cancer: back to Virchow? Lancet. 2001;357:539–45.
-
(2001)
Lancet
, vol.357
, pp. 539-545
-
-
Balkwill, F.1
Mantovani, A.2
-
17
-
-
26244431936
-
Helicobacter pylori and gastric epithelial cells: from gastritis to cancer
-
COI: 1:CAS:528:DC%2BD2MXhtFGqsbjO
-
Penta R, De Falco M, Iaquinto G, De Luca A. Helicobacter pylori and gastric epithelial cells: from gastritis to cancer. J Exp Clin Cancer Res CR. 2005;24:337–45.
-
(2005)
J Exp Clin Cancer Res CR
, vol.24
, pp. 337-345
-
-
Penta, R.1
De Falco, M.2
Iaquinto, G.3
De Luca, A.4
-
18
-
-
84856429876
-
Obesity, inflammation, and liver cancer
-
COI: 1:CAS:528:DC%2BC38XislWjs7c%3D, PID: 22120206
-
Sun B, Karin M. Obesity, inflammation, and liver cancer. J Hepatol. 2012;56:704–13.
-
(2012)
J Hepatol
, vol.56
, pp. 704-713
-
-
Sun, B.1
Karin, M.2
-
19
-
-
82255162065
-
Preoperative platelet lymphocyte ratio as an independent prognostic marker in ovarian cancer
-
PID: 21775277
-
Asher V, Lee J, Innamaa A, Bali A. Preoperative platelet lymphocyte ratio as an independent prognostic marker in ovarian cancer. Clin Transl Oncol. 2011;13:499–503.
-
(2011)
Clin Transl Oncol
, vol.13
, pp. 499-503
-
-
Asher, V.1
Lee, J.2
Innamaa, A.3
Bali, A.4
-
20
-
-
84903381441
-
Prognostic value of PLR in various cancers: a meta-analysis
-
PID: 24968121
-
Zhou X, Du Y, Huang Z, Xu J, Qiu T, Wang J, et al. Prognostic value of PLR in various cancers: a meta-analysis. PLoS One. 2014;9:e101119.
-
(2014)
PLoS One
, vol.9
, pp. e101119
-
-
Zhou, X.1
Du, Y.2
Huang, Z.3
Xu, J.4
Qiu, T.5
Wang, J.6
-
21
-
-
29144514645
-
Effector memory T cells, early metastasis, and survival in colorectal cancer
-
COI: 1:CAS:528:DC%2BD2MXhtlarsrrE, PID: 16371631
-
Pages F, Berger A, Camus M, Sanchez-Cabo F, Costes A, Molidor R, et al. Effector memory T cells, early metastasis, and survival in colorectal cancer. N Engl J Med. 2005;353:2654–66.
-
(2005)
N Engl J Med
, vol.353
, pp. 2654-2666
-
-
Pages, F.1
Berger, A.2
Camus, M.3
Sanchez-Cabo, F.4
Costes, A.5
Molidor, R.6
-
22
-
-
34447277894
-
Intratumoral balance of regulatory and cytotoxic T cells is associated with prognosis of hepatocellular carcinoma after resection
-
PID: 17577038
-
Gao Q, Qiu SJ, Fan J, Zhou J, Wang XY, Xiao YS, et al. Intratumoral balance of regulatory and cytotoxic T cells is associated with prognosis of hepatocellular carcinoma after resection. J Clin Oncol. 2007;25:2586–93.
-
(2007)
J Clin Oncol
, vol.25
, pp. 2586-2593
-
-
Gao, Q.1
Qiu, S.J.2
Fan, J.3
Zhou, J.4
Wang, X.Y.5
Xiao, Y.S.6
-
23
-
-
34247271873
-
CD8 tumor-infiltrating lymphocytes are predictive of survival in muscle-invasive urothelial carcinoma
-
COI: 1:CAS:528:DC%2BD2sXjt1ymu7g%3D, PID: 17360461
-
Sharma P, Shen Y, Wen S, Yamada S, Jungbluth AA, Gnjatic S, et al. CD8 tumor-infiltrating lymphocytes are predictive of survival in muscle-invasive urothelial carcinoma. Proc Natl Acad Sci U S A. 2007;104:3967–72.
-
(2007)
Proc Natl Acad Sci U S A
, vol.104
, pp. 3967-3972
-
-
Sharma, P.1
Shen, Y.2
Wen, S.3
Yamada, S.4
Jungbluth, A.A.5
Gnjatic, S.6
-
24
-
-
33749319703
-
Type, density, and location of immune cells within human colorectal tumors predict clinical outcome
-
COI: 1:CAS:528:DC%2BD28XhtVSnsrnK, PID: 17008531
-
Galon J, Costes A, Sanchez-Cabo F, Kirilovsky A, Mlecnik B, Lagorce-Pages C, et al. Type, density, and location of immune cells within human colorectal tumors predict clinical outcome. Science. 2006;313:1960–4.
-
(2006)
Science
, vol.313
, pp. 1960-1964
-
-
Galon, J.1
Costes, A.2
Sanchez-Cabo, F.3
Kirilovsky, A.4
Mlecnik, B.5
Lagorce-Pages, C.6
-
25
-
-
55949118778
-
Prognostic implications of type and density of tumour-infiltrating lymphocytes in gastric cancer
-
COI: 1:CAS:528:DC%2BD1cXhtlGrur%2FE, PID: 18941457
-
Lee HE, Chae SW, Lee YJ, Kim MA, Lee HS, Lee BL, et al. Prognostic implications of type and density of tumour-infiltrating lymphocytes in gastric cancer. Br J Cancer. 2008;99:1704–11.
-
(2008)
Br J Cancer
, vol.99
, pp. 1704-1711
-
-
Lee, H.E.1
Chae, S.W.2
Lee, Y.J.3
Kim, M.A.4
Lee, H.S.5
Lee, B.L.6
-
27
-
-
0035180065
-
Immunologic tolerance maintained by CD25+ CD4+ regulatory T cells: their common role in controlling autoimmunity, tumor immunity, and transplantation tolerance
-
COI: 1:CAS:528:DC%2BD3MXpt1eis7c%3D, PID: 11722621
-
Sakaguchi S, Sakaguchi N, Shimizu J, Yamazaki S, Sakihama T, Itoh M, et al. Immunologic tolerance maintained by CD25+ CD4+ regulatory T cells: their common role in controlling autoimmunity, tumor immunity, and transplantation tolerance. Immunol Rev. 2001;182:18–32.
-
(2001)
Immunol Rev
, vol.182
, pp. 18-32
-
-
Sakaguchi, S.1
Sakaguchi, N.2
Shimizu, J.3
Yamazaki, S.4
Sakihama, T.5
Itoh, M.6
-
28
-
-
49749084339
-
Intratumoural FOXP3-positive regulatory T cells are associated with adverse prognosis in radically resected gastric cancer
-
COI: 1:CAS:528:DC%2BD1cXhtVamt7rE, PID: 18617393
-
Perrone G, Ruffini PA, Catalano V, Spino C, Santini D, Muretto P, et al. Intratumoural FOXP3-positive regulatory T cells are associated with adverse prognosis in radically resected gastric cancer. Eur J Cancer. 2008;44:1875–82.
-
(2008)
Eur J Cancer
, vol.44
, pp. 1875-1882
-
-
Perrone, G.1
Ruffini, P.A.2
Catalano, V.3
Spino, C.4
Santini, D.5
Muretto, P.6
-
29
-
-
70349423483
-
Intraepithelial effector (CD3+)/regulatory (FoxP3+) T-cell ratio predicts a clinical outcome of human colon carcinoma
-
COI: 1:CAS:528:DC%2BD1MXht12gtr%2FP, PID: 19577568
-
Sinicrope FA, Rego RL, Ansell SM, Knutson KL, Foster NR, Sargent DJ. Intraepithelial effector (CD3+)/regulatory (FoxP3+) T-cell ratio predicts a clinical outcome of human colon carcinoma. Gastroenterology. 2009;137:1270–9.
-
(2009)
Gastroenterology
, vol.137
, pp. 1270-1279
-
-
Sinicrope, F.A.1
Rego, R.L.2
Ansell, S.M.3
Knutson, K.L.4
Foster, N.R.5
Sargent, D.J.6
-
30
-
-
34250005419
-
Increased regulatory t cells correlate with CD8 T-cell impairment and poor survival in hepatocellular carcinoma patients
-
PID: 17570208
-
Fu J, Xu D, Liu Z, Shi M, Zhao P, Fu B, et al. Increased regulatory t cells correlate with CD8 T-cell impairment and poor survival in hepatocellular carcinoma patients. Gastroenterology. 2007;132:2328–39.
-
(2007)
Gastroenterology
, vol.132
, pp. 2328-2339
-
-
Fu, J.1
Xu, D.2
Liu, Z.3
Shi, M.4
Zhao, P.5
Fu, B.6
-
31
-
-
33244472107
-
Tumor-infiltrating T lymphocytes: friends or foes? Laboratory investigation
-
COI: 1:CAS:528:DC%2BD28XhsFSmurk%3D
-
Yu P, Fu YX. Tumor-infiltrating T lymphocytes: friends or foes? Laboratory investigation. J Tech Methods Pathol. 2006;86:231–45.
-
(2006)
J Tech Methods Pathol
, vol.86
, pp. 231-245
-
-
Yu, P.1
Fu, Y.X.2
-
32
-
-
79953065052
-
Tumor-infiltrating CD4+ Th17 cells produce IL-17 in tumor microenvironment and promote tumor progression in human gastric cancer
-
COI: 1:CAS:528:DC%2BC3MXmtlagsL4%3D, PID: 21369705
-
Iida T, Iwahashi M, Katsuda M, Ishida K, Nakamori M, Nakamura M, et al. Tumor-infiltrating CD4+ Th17 cells produce IL-17 in tumor microenvironment and promote tumor progression in human gastric cancer. Oncol Rep. 2011;25:1271–7.
-
(2011)
Oncol Rep
, vol.25
, pp. 1271-1277
-
-
Iida, T.1
Iwahashi, M.2
Katsuda, M.3
Ishida, K.4
Nakamori, M.5
Nakamura, M.6
-
33
-
-
84862278783
-
T cells in gastric cancer: friends or foes
-
PID: 22693525
-
Amedei A, Della Bella C, Silvestri E, Prisco D, D’Elios MM. T cells in gastric cancer: friends or foes. Clin Dev Immunol. 2012;2012:690571.
-
(2012)
Clin Dev Immunol
, vol.2012
, pp. 690571
-
-
Amedei, A.1
Della Bella, C.2
Silvestri, E.3
Prisco, D.4
D’Elios, M.M.5
-
34
-
-
67650481213
-
Lymphopenia as a prognostic factor for overall survival in advanced carcinomas, sarcomas, and lymphomas
-
COI: 1:CAS:528:DC%2BD1MXnvFWqu7c%3D, PID: 19549917
-
Ray-Coquard I, Cropet C, Van Glabbeke M, Sebban C, Le Cesne A, Judson I, et al. Lymphopenia as a prognostic factor for overall survival in advanced carcinomas, sarcomas, and lymphomas. Cancer Res. 2009;69:5383–91.
-
(2009)
Cancer Res
, vol.69
, pp. 5383-5391
-
-
Ray-Coquard, I.1
Cropet, C.2
Van Glabbeke, M.3
Sebban, C.4
Le Cesne, A.5
Judson, I.6
-
35
-
-
84864764730
-
Relationship between lymphocytopenia and circulating tumor cells as prognostic factors for overall survival in metastatic breast cancer
-
PID: 22591634
-
De Giorgi U, Mego M, Scarpi E, Giuliano M, Giordano A, Reuben JM, et al. Relationship between lymphocytopenia and circulating tumor cells as prognostic factors for overall survival in metastatic breast cancer. Clin Breast Cancer. 2012;12:264–9.
-
(2012)
Clin Breast Cancer
, vol.12
, pp. 264-269
-
-
De Giorgi, U.1
Mego, M.2
Scarpi, E.3
Giuliano, M.4
Giordano, A.5
Reuben, J.M.6
-
36
-
-
0029851566
-
The prognostic significance of immune changes in patients with renal cancer, melanoma and colorectal cancer, treated with interferon alpha 2b
-
COI: 1:CAS:528:DyaK2sXjs1Gntw%3D%3D
-
Tsavaris N, Baxevanis C, Kosmidis P, Papamichael M. The prognostic significance of immune changes in patients with renal cancer, melanoma and colorectal cancer, treated with interferon alpha 2b. Cancer Immunol Immunother CII. 1996;43:94–102.
-
(1996)
Cancer Immunol Immunother CII
, vol.43
, pp. 94-102
-
-
Tsavaris, N.1
Baxevanis, C.2
Kosmidis, P.3
Papamichael, M.4
-
37
-
-
0141483735
-
Lymphocyte counts independently predict overall survival in advanced cancer patients: a biomarker for IL-2 immunotherapy
-
COI: 1:CAS:528:DC%2BD3sXnt1ansr4%3D, PID: 12973028
-
Fumagalli LA, Vinke J, Hoff W, Ypma E, Brivio F, Nespoli A. Lymphocyte counts independently predict overall survival in advanced cancer patients: a biomarker for IL-2 immunotherapy. J Immunother. 2003;26:394–402.
-
(2003)
J Immunother
, vol.26
, pp. 394-402
-
-
Fumagalli, L.A.1
Vinke, J.2
Hoff, W.3
Ypma, E.4
Brivio, F.5
Nespoli, A.6
-
38
-
-
4243107385
-
Efficacy of cancer chemotherapy in relation to the pretreatment number of lymphocytes in patients with metastatic solid tumors
-
COI: 1:STN:280:DC%2BD2czlt1Gqtw%3D%3D, PID: 15255546
-
Lissoni P, Brivio F, Fumagalli L, Messina G, Ghezzi V, Frontini L, et al. Efficacy of cancer chemotherapy in relation to the pretreatment number of lymphocytes in patients with metastatic solid tumors. Int J Biol Markers. 2004;19:135–40.
-
(2004)
Int J Biol Markers
, vol.19
, pp. 135-140
-
-
Lissoni, P.1
Brivio, F.2
Fumagalli, L.3
Messina, G.4
Ghezzi, V.5
Frontini, L.6
-
39
-
-
84944360622
-
Absolute granulocyte, lymphocyte, and monocyte counts. Useful determinants of prognosis for patients with metastatic cancer of the stomach
-
COI: 1:STN:280:DyaL387it1ymug%3D%3D, PID: 7035703
-
Bruckner HW, Lavin PT, Plaxe SC, Storch JA, Livstone EM. Absolute granulocyte, lymphocyte, and monocyte counts. Useful determinants of prognosis for patients with metastatic cancer of the stomach. JAMA. 1982;247:1004–6.
-
(1982)
JAMA
, vol.247
, pp. 1004-1006
-
-
Bruckner, H.W.1
Lavin, P.T.2
Plaxe, S.C.3
Storch, J.A.4
Livstone, E.M.5
-
40
-
-
33745161801
-
Prognostic value of preoperative peripheral blood monocyte count in patients with hepatocellular carcinoma
-
PID: 16782430
-
Sasaki A, Iwashita Y, Shibata K, Matsumoto T, Ohta M, Kitano S. Prognostic value of preoperative peripheral blood monocyte count in patients with hepatocellular carcinoma. Surgery. 2006;139:755–64.
-
(2006)
Surgery
, vol.139
, pp. 755-764
-
-
Sasaki, A.1
Iwashita, Y.2
Shibata, K.3
Matsumoto, T.4
Ohta, M.5
Kitano, S.6
-
41
-
-
83055184394
-
Prognostic value of pre-treatment circulating monocyte count in patients with cervical cancer: comparison with SCC-Ag level
-
PID: 22014631
-
Lee YY, Choi CH, Sung CO, Do IG, Huh S, Song T, et al. Prognostic value of pre-treatment circulating monocyte count in patients with cervical cancer: comparison with SCC-Ag level. Gynecol Oncol. 2012;124:92–7.
-
(2012)
Gynecol Oncol
, vol.124
, pp. 92-97
-
-
Lee, Y.Y.1
Choi, C.H.2
Sung, C.O.3
Do, I.G.4
Huh, S.5
Song, T.6
-
42
-
-
3042749576
-
Role of infiltrated leucocytes in tumour growth and spread
-
COI: 1:STN:280:DC%2BD2czht1SqsQ%3D%3D, PID: 15164120
-
Lin EY, Pollard JW. Role of infiltrated leucocytes in tumour growth and spread. Br J Cancer. 2004;90:2053–8.
-
(2004)
Br J Cancer
, vol.90
, pp. 2053-2058
-
-
Lin, E.Y.1
Pollard, J.W.2
-
43
-
-
0031876304
-
Production of vascular endothelial growth factor by murine macrophages: regulation by hypoxia, lactate, and the inducible nitric oxide synthase pathway
-
COI: 1:CAS:528:DyaK1cXls1ejtb4%3D, PID: 9708818
-
Xiong M, Elson G, Legarda D, Leibovich SJ. Production of vascular endothelial growth factor by murine macrophages: regulation by hypoxia, lactate, and the inducible nitric oxide synthase pathway. Am J Pathol. 1998;153:587–98.
-
(1998)
Am J Pathol
, vol.153
, pp. 587-598
-
-
Xiong, M.1
Elson, G.2
Legarda, D.3
Leibovich, S.J.4
-
44
-
-
0005339099
-
Tumor-associated macrophages in breast cancer
-
PID: 12463738
-
Leek RD, Harris AL. Tumor-associated macrophages in breast cancer. J Mammary Gland Biol Neoplasia. 2002;7:177–89.
-
(2002)
J Mammary Gland Biol Neoplasia
, vol.7
, pp. 177-189
-
-
Leek, R.D.1
Harris, A.L.2
-
45
-
-
84893858450
-
Transforming growth factor-beta and matrix metalloproteinases: functional interactions in tumor stroma-infiltrating myeloid cells
-
Krstic J, Santibanez JF. Transforming growth factor-beta and matrix metalloproteinases: functional interactions in tumor stroma-infiltrating myeloid cells. Sci World J. 2014;2014:521754.
-
(2014)
Sci World J
, vol.2014
, pp. 521754
-
-
Krstic, J.1
Santibanez, J.F.2
-
46
-
-
84858785703
-
Coordinated regulation of myeloid cells by tumours
-
COI: 1:CAS:528:DC%2BC38XksVensrs%3D, PID: 22437938
-
Gabrilovich DI, Ostrand-Rosenberg S, Bronte V. Coordinated regulation of myeloid cells by tumours. Nat Rev Immunol. 2012;12:253–68.
-
(2012)
Nat Rev Immunol
, vol.12
, pp. 253-268
-
-
Gabrilovich, D.I.1
Ostrand-Rosenberg, S.2
Bronte, V.3
-
47
-
-
84899709874
-
Myeloid-derived suppressor cells in cancer: therapeutic, predictive, and prognostic implications
-
COI: 1:CAS:528:DC%2BC2cXns1Cltb0%3D, PID: 24787291
-
Diaz-Montero CM, Finke J, Montero AJ. Myeloid-derived suppressor cells in cancer: therapeutic, predictive, and prognostic implications. Semin Oncol. 2014;41:174–84.
-
(2014)
Semin Oncol
, vol.41
, pp. 174-184
-
-
Diaz-Montero, C.M.1
Finke, J.2
Montero, A.J.3
-
48
-
-
84864662070
-
Multipeptide immune response to cancer vaccine IMA901 after single-dose cyclophosphamide associates with longer patient survival
-
COI: 1:CAS:528:DC%2BC38XhtFWmsL%2FJ, PID: 22842478
-
Walter S, Weinschenk T, Stenzl A, Zdrojowy R, Pluzanska A, Szczylik C, et al. Multipeptide immune response to cancer vaccine IMA901 after single-dose cyclophosphamide associates with longer patient survival. Nat Med. 2012;18:1254–61.
-
(2012)
Nat Med
, vol.18
, pp. 1254-1261
-
-
Walter, S.1
Weinschenk, T.2
Stenzl, A.3
Zdrojowy, R.4
Pluzanska, A.5
Szczylik, C.6
-
49
-
-
84880924329
-
Increase in CD14 + HLA-DR -/low myeloid-derived suppressor cells in hepatocellular carcinoma patients and its impact on prognosis
-
COI: 1:CAS:528:DC%2BC3sXht1CrtrvI
-
Arihara F, Mizukoshi E, Kitahara M, Takata Y, Arai K, Yamashita T, et al. Increase in CD14 + HLA-DR -/low myeloid-derived suppressor cells in hepatocellular carcinoma patients and its impact on prognosis. Cancer Immunol Immunother CII. 2013;62:1421–30.
-
(2013)
Cancer Immunol Immunother CII
, vol.62
, pp. 1421-1430
-
-
Arihara, F.1
Mizukoshi, E.2
Kitahara, M.3
Takata, Y.4
Arai, K.5
Yamashita, T.6
-
50
-
-
84883447186
-
Increased CD14(+)HLA-DR (-/low) myeloid-derived suppressor cells correlate with extrathoracic metastasis and poor response to chemotherapy in non-small cell lung cancer patients
-
COI: 1:CAS:528:DC%2BC3sXhsFKjsbrI
-
Huang A, Zhang B, Wang B, Zhang F, Fan KX, Guo YJ. Increased CD14(+)HLA-DR (-/low) myeloid-derived suppressor cells correlate with extrathoracic metastasis and poor response to chemotherapy in non-small cell lung cancer patients. Cancer Immunol Immunother CII. 2013;62:1439–51.
-
(2013)
Cancer Immunol Immunother CII
, vol.62
, pp. 1439-1451
-
-
Huang, A.1
Zhang, B.2
Wang, B.3
Zhang, F.4
Fan, K.X.5
Guo, Y.J.6
|